Sutro Biopharma Inc (STRO) Stock Falls -4.32% This Week: Is It a Good Pick?

Sutro Biopharma Inc (STRO) stock is lower by -74.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives STRO stock a score of 24 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 4. STRO's rank also includes a short-term technical score of 6. The fundamental score for STRO is 63. In addition to the average rating from Wall Street analysts, STRO stock has a mean target price of $30.67. This means analysts expect the stock to gain 501.29% over the next 12 months.

STRO has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on STRO!

See Full STRO Report

What's Happening with STRO Stock Today

Sutro Biopharma Inc (STRO) stock is up 7.59% while the S&P 500 has risen 1.79% as of 4:00 PM on Tuesday, May 17. STRO has risen $0.36 from the previous closing price of $4.74 on volume of 442,741 shares. Over the past year the S&P 500 is lower by -2.01% while STRO is lower by -74.23%. STRO lost -$2.47 per share in the over the last 12 months. Click Here to get the full Stock Report for Sutro Biopharma Inc stock.